Overall, we do not find any significant differences in the distribution of majority of the clinical features across the two subtypes with the exception of tumor stage, tissue type (primary vs metastatic) and PD-L1 scores (Supplementary Fig. 5). The gene discussed is CD274; the disease is neoplasm.